1.THE EFFECT OF SURFACE TREATMENT ON FRACTURE STRENGTH OF DENTAL CERAMICS.
Shin Won LEE ; Sun Hyung LEE ; Jae Ho YANG ; Hun Young CHUNG
The Journal of Korean Academy of Prosthodontics 1999;37(5):658-671
The major influencing factors on the strength of all-ceramic crowns are types of dental ceramics, fabrication techniques, methods of abutment preparation and cementation modes of all ceramic restorations. Zine phosphate cement and glass-ionomer cement were used as an early luting media for all-ceramic crowns. Recently many studies have reported that resin cements have more advantages in increasing the fracture strength of restorations comparing with zincphosphate cement and glass-ionomer cement. The purpose of this study is to investigate the effect of etching, silane treatment, sandblasting and dentin bonding agents on fracture strengths of dental ceramics. 40 flat dentin specimens and 40 ceramic discs of 1.5mm thickness and 8mm diameter were fabricated, and divided into 4 groups according to surface treatments. Surface treatments before cementation were as follows. Group I : (ceramic) : HF etching - silane treatment - application of bonding resin (dentin) : application of dentin bonding agent Group II : (ceramic) : sandblasting - application of bonding resin (dentin) : application of dentin bonding agent Group III : (ceramic) : application of bonding resin (dentin) : application of dentin bonding agent Group IV : (ceramic) : HF etching - silane treatment - application of bonding resin (dentin) : no dentin bonding procedure Dentin specimens and ceramic discs were cemented with dual cure resin cement, and went through thermocycling. Compressive stress es were loaded on the centers of ceramic discs with Instron testing machine, and fracture strengths resista' nce for catastrophic fracture were measured The results were as follows. 1. The group I showed the highest fracture resistance. The next was group II. And group III, IV followed. 2. There was a significant difference in the mean value of fracture strengths between group I and group III (p<0.05), but no significant differences between group I and group II, and group II and group III (p>0.05). 3. There was a significant difference in the mean value of fracture strengths between group I and group IV (p<0.05).
Cementation
;
Ceramics*
;
Crowns
;
Dentin
;
Dentin-Bonding Agents
;
Glass Ionomer Cements
;
Resin Cements
2.U-U shape 1-layer microsurgical vasovasostomy: 343 cases.
Jae Sup SHIN ; Hun Goo HAH ; Woong Hee LEE ; Hyung Ki CHOI ; Zong Ceung XIN
Korean Journal of Fertility and Sterility 1993;20(3):285-290
No abstract available.
Vasovasostomy*
3.Rhinocerebral Mucormycosis with Intracerebral Hemorrhage.
Pill Jae SHIN ; Ho Kook LEE ; Chang Hyun KIM ; Kyung Hun YANG ; Do Yun HWANG
Journal of Korean Neurosurgical Society 2000;29(1):136-142
No abstract available.
Cerebral Hemorrhage*
;
Mucormycosis*
4.A Case of Chronic Gonorrheal Orbital Cellulitis.
Wan Hun KOO ; Sang Shin KIM ; Dong Jae LEE
Journal of the Korean Ophthalmological Society 1977;18(4):405-407
Authors have experienced a case of long standing chronic gonorrheal orbital cellulitis in a 50 years old Korean male. Surgical evacuation of pus discharges and microscopcially confirmed the gram negative intncellular and extracellular gonococcus. A brief review of the related literatures is present.
Humans
;
Male
;
Middle Aged
;
Neisseria gonorrhoeae
;
Orbit*
;
Orbital Cellulitis*
;
Suppuration
5.A case report of Angle's Class I malocclusion.
Jae Eui SHIN ; Sang Hun JANG ; Dong Seok NAHM ; Hee Won CHO
Korean Journal of Orthodontics 1972;3(1):35-40
No abstract available.
Malocclusion*
6.Pain Control with Continuous Infusion of Epidural Morphine and Bupivacaine after Lumbar Spinal Surgery(A Prospective Study).
Moon Soo SHIN ; Byung Hee LEE ; Hun Kyu CHOI ; Jae Sub NOH ; Jung Young AHN ; Seung Hun SHEEN ; Byung Hee LEE ; Bong Sub CHUNG
Journal of Korean Neurosurgical Society 2000;29(5):604-608
No abstract available.
Bupivacaine*
;
Morphine*
;
Prospective Studies*
7.Comparative Study of 0.1% and 0.2% Bupivacaine Combined with Fentanyl 5 microgram/ml for Patient Controlled Epidural Analgesia after Gynecological Lower Abdominal Surgery.
Sang Beom NAM ; Kyoung Hun KIM ; Jae Ki LEE ; Jong Hun JUN ; Woo Jong SHIN
Korean Journal of Anesthesiology 1999;36(4):685-690
BACKGROUND: The addition of bupivacaine to lipid soluble opioids have improved analgesia and can reduce opioid related side effects in the epidural analgesia. The use of the combination of bupivacaine and lipid soluble opioid fentanyl is gaining in popularity after surgery. But recent work has produced conflicting results, and the ideal combination of local anesthetics and opioid for Patient Controlled Epidural Analgesia (PCEA) is unknown. We have compared the efficacy and the safety of 0.1% bupivacaine and 0.2% bupivacaine combined with fentanyl 5 microgram/ml for PCEA. METHODS: Forty women undergoing lower abdominal gynecological surgery under general anesthesia were assigned to receive an epidural initial bolus of 0.1% (0.1% group) or 0.2% bupivacaine (0.2% group) combined with 5 microgram/ml fentanyl mixture 10 ml, followed by a PCEA with 2 ml/hr continuous background infusion and demand-dose of 2 ml in prospective, random, double blind fashion. Resting and coughing visual analogue scale (VAS) for pain, infusion rates of the mixture, and side effects were recorded at 4, 8, 24, 48 hr postoperatively, and satisfaction were noted after 48 hr. RESULTS: No differences in resting and coughing VAS scores, hypotension, nausea, itching sensation, and somnolence were observed between the two groups. The mean infusion rates of mixtures during the first 4 hr were higher in the 0.1% group (3.3 1.3 ml/hr) than the 0.2% group (2.5 0.6 ml/hr) (p<0.05). The incidence and the degree of sensory and motor block were higher in the 0.2% group (p<0.05). CONCLUSIONS: Both groups provided sufficient postoperative analgesia and satisfaction with some side effects. The high incidence and degree of sensory and motor block were resulted in the 0.2% group, which is not optimal for early ambulation. To search for more titrated bupivacaine concentration between 0.1% and 0.2%, loading doses or appropriate epidural puncture level having reduced demand dose and decreased side effects, further studies are expected.
Analgesia
;
Analgesia, Epidural*
;
Analgesics, Opioid
;
Anesthesia, General
;
Anesthetics, Local
;
Bupivacaine*
;
Cough
;
Early Ambulation
;
Female
;
Fentanyl*
;
Gynecologic Surgical Procedures
;
Humans
;
Hypotension
;
Incidence
;
Nausea
;
Prospective Studies
;
Pruritus
;
Punctures
;
Sensation
8.Co-occurrence of both maternally inherited neurofibromatosis type 1 and Lesch-Nyhan disease in a child with severe neurodevelopmental impairment
Jae Hun YUN ; Yong Hee HONG ; Go Hun SEO ; Young-Lim SHIN
Journal of Genetic Medicine 2022;19(2):94-99
Lesch-Nyhan disease (LND) is a rare X-linked recessive inherited purine metabolic disorder that accompanies neurodevelopmental problems. Neurofibromatosis type 1 (NF1) is a relatively common autosomal dominant inherited genetic disorder characterized by tumors in various systems. Some children with NF1 also accompanies neurodevelopmental problems.Here, we describe a 5-year-old boy with a maternally inherited pathogenic variant in NF-1 and hypoxanthine-guanine phosphoribosyltransferase (HPRT ). He was referred for severe neurodevelopmental impairment and hyperuricemia. His mother was diagnosed with NF1 and the patient was also suspected of having NF1 because of cafe au lait macules. He had dystonia, rigidity, cognitive deficit, and speech/language impairment. Serum and urine uric acid concentrations were elevated. He had more severe neurodevelopmental delay than patients with only NF1, so his clinical symptoms could not be fully understood by the disease alone. To find the cause of his neurologic symptoms and hyperuricemia, the patient and his mother underwent a whole-exome sequencing test. As a result, the pathogenic variant c.151C>T (p.Arg51Ter) in HPRT1 was identified as hemizygote in the patient and heterozygote in his mother. The pathogenic variant c.7682C>G (p.Ser2561Ter) in NF-1 was identified as heterozygotes in both of them. Although the clinical symptoms of both diseases were overlapping and complicated, genetic testing was helpful for accurate diagnosis and treatment. Therefore, we suggest to consider preemptive genetic evaluation if there are symptoms not sufficiently explained by known existing diseases. And it is considered valuable to review this rare case to understand the clinical course and possible synergic effects of these diseases.
9.The Effect of Nicardipine on Capacitative Calcium Entry in Canine Pulmonary Arterial Smooth Muscle Cells.
Jong Hun YEOM ; Hye in SHIN ; Jae Hang SHIM ; Woo Jae JEON ; Sang Yoon CHO ; Woo Jong SHIN ; Kyoung Hun KIM
Korean Journal of Anesthesiology 2003;44(4):555-561
BACKGORUND: Capacitive calcium entry involves the influx of Ca2+ across the sarcolemma in response to the depletion of intracellular Ca2+ stores. Presently, little is known about the nature of the intracellular Ca2+ store (s) in pulmonary arterial smooth muscle cells (PASMCs), even though the unique contractile response of this tissue to hypoxia may at least partially involve the intracellular release of Ca2+ . The authors aimed to investigate the effects of nicardipine on capacitative calcium entry. METHODS: isolated pulmonary smooth muscle cells were obtained from enzymatically treated canine pulmonary artery. Currents were recorded at room temperature using the dialyzed whole cell recording technique. The protocol used to deplete intracellular Ca2+ stores and to monitor the development of the store-operated Ca2+ currents, involved cells being were voltage-clamped at 0 mv to inactivate any voltage-dependent calcium currents, which were recorded in response to a 200 ms voltage step from 120 to 40 mV in 20 mV increments. RESULTS: Simultaneous depletion of intracellular Ca2+ leads to linear store-operated Ca2+ current (iSOC) reversal near 0 mV. Nicardipine does not affect iSOC. CONCLUSiONS: in canine PASMCs, the depletion of intracellular Ca2+ stores leads to the activation of iSOC, which is not inhibited by nicardipine, a voltage-dependent Ca2+ channel (VDCC) blocker, indicating that VDCC blocked by nicardipine does not contribute to CCE in canine PASMCs.
Anoxia
;
Calcium Channels
;
Calcium*
;
Muscle, Smooth*
;
Myocytes, Smooth Muscle*
;
Nicardipine*
;
Patch-Clamp Techniques
;
Pulmonary Artery
;
Sarcolemma
10.A case of D13 ring chromosome syndrome.
Sung Lae PARK ; Ho Jun IM ; Jae Hun SHIN ; Hahng LEE ; Myung Soo LYU ; Yong Kyun PAIK
Journal of the Korean Pediatric Society 1992;35(5):713-717
No abstract available.
Ring Chromosomes*